2023 Q2 Form 10-Q Financial Statement

#000155837023007874 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $300.3M $282.3M
YoY Change 49.01% 30.96%
Cost Of Revenue $260.3M $251.9M
YoY Change 42.16% 25.8%
Gross Profit $39.93M $30.42M
YoY Change 117.31% 98.29%
Gross Profit Margin 13.3% 10.78%
Selling, General & Admin $19.48M $17.92M
YoY Change 53.98% 44.71%
% of Gross Profit 48.79% 58.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.213M $3.148M
YoY Change 13.53% 12.71%
% of Gross Profit 8.05% 10.35%
Operating Expenses $19.48M $17.92M
YoY Change 53.98% 44.71%
Operating Profit $20.45M $12.49M
YoY Change 257.31% 322.92%
Interest Expense $1.700M $1.012M
YoY Change 170.7% 142.11%
% of Operating Profit 8.31% 8.1%
Other Income/Expense, Net -$44.00K -$20.00K
YoY Change -222.22%
Pretax Income $18.98M $11.80M
YoY Change 293.73% 375.0%
Income Tax $4.063M $2.579M
% Of Pretax Income 21.41% 21.86%
Net Earnings $14.92M $9.220M
YoY Change 296.99% 346.49%
Net Earnings / Revenue 4.97% 3.27%
Basic Earnings Per Share $1.30 $0.81
Diluted Earnings Per Share $1.29 $0.81
COMMON SHARES
Basic Shares Outstanding 11.44M 11.42M
Diluted Shares Outstanding 11.53M 11.43M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.50M $29.72M
YoY Change -2.01% 1.46%
Cash & Equivalents $30.50M $29.72M
Short-Term Investments
Other Short-Term Assets $6.393M $6.771M
YoY Change -14.14% -22.56%
Inventory $167.5M $164.4M
Prepaid Expenses $6.393M $6.771M
Receivables $264.5M $233.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $468.9M $434.0M
YoY Change 26.38% 21.83%
LONG-TERM ASSETS
Property, Plant & Equipment $116.1M $111.0M
YoY Change 2.21% 13.49%
Goodwill $20.59M $11.62M
YoY Change 77.24% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $681.0K $686.0K
YoY Change 10.19% 7.02%
Total Long-Term Assets $138.1M $124.1M
YoY Change 8.88% 11.61%
TOTAL ASSETS
Total Short-Term Assets $468.9M $434.0M
Total Long-Term Assets $138.1M $124.1M
Total Assets $607.0M $558.2M
YoY Change 21.92% 19.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $188.9M $169.5M
YoY Change 37.16% 21.64%
Accrued Expenses $34.54M $30.26M
YoY Change 35.99% 31.49%
Deferred Revenue $242.0K $242.0K
YoY Change -5.84% -5.84%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $224.6M $204.8M
YoY Change 37.43% 25.87%
LONG-TERM LIABILITIES
Long-Term Debt $60.00M $45.00M
YoY Change 50.0% 350.0%
Other Long-Term Liabilities $496.0K $569.0K
YoY Change -31.3% -30.27%
Total Long-Term Liabilities $60.00M $45.00M
YoY Change 50.0% 350.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $224.6M $204.8M
Total Long-Term Liabilities $60.00M $45.00M
Total Liabilities $291.3M $256.5M
YoY Change 39.11% 43.59%
SHAREHOLDERS EQUITY
Retained Earnings $170.1M $157.3M
YoY Change 18.46% 10.82%
Common Stock $114.0K $114.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $315.7M $301.7M
YoY Change
Total Liabilities & Shareholders Equity $607.0M $558.2M
YoY Change 21.92% 19.4%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $14.92M $9.220M
YoY Change 296.99% 346.49%
Depreciation, Depletion And Amortization $3.213M $3.148M
YoY Change 13.53% 12.71%
Cash From Operating Activities $9.674M -$6.764M
YoY Change -264.22% -76.62%
INVESTING ACTIVITIES
Capital Expenditures $4.861M $1.749M
YoY Change -125.93% -57.25%
Acquisitions
YoY Change
Other Investing Activities -$17.56M $0.00
YoY Change -100.0%
Cash From Investing Activities -$22.42M -$1.749M
YoY Change 19.6% -57.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.94M -2.059M
YoY Change -53.69% -125.94%
NET CHANGE
Cash From Operating Activities 9.674M -6.764M
Cash From Investing Activities -22.42M -1.749M
Cash From Financing Activities 12.94M -2.059M
Net Change In Cash 190.0K -10.43M
YoY Change -94.24% -58.33%
FREE CASH FLOW
Cash From Operating Activities $9.674M -$6.764M
Capital Expenditures $4.861M $1.749M
Free Cash Flow $4.813M -$8.513M
YoY Change -62.57% -74.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
847000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
909000
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000924822
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 mlr Percent Of Impacted Accounts
PercentOfImpactedAccounts
0.036
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-14124
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
MILLER INDUSTRIES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TN
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1566286
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8503 Hilltop Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Ooltewah
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37363
CY2023Q1 dei City Area Code
CityAreaCode
423
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
238-4171
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
MLR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11441036
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29720000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40153000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1364000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1319000
CY2023Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
233115000
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
177663000
CY2023Q1 us-gaap Inventory Net
InventoryNet
164431000
CY2022Q4 us-gaap Inventory Net
InventoryNet
153656000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6771000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4576000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
434037000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
376048000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110976000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
112145000
CY2023Q1 us-gaap Goodwill
Goodwill
11619000
CY2022Q4 us-gaap Goodwill
Goodwill
11619000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
686000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
708000
CY2023Q1 us-gaap Assets
Assets
558165000
CY2022Q4 us-gaap Assets
Assets
501429000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
169458000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
125500000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30264000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27904000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4741000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2430000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
307000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
311000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
204770000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
156145000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
45000000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
45000000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
569000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
597000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6159000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6230000
CY2023Q1 us-gaap Liabilities
Liabilities
256498000
CY2022Q4 us-gaap Liabilities
Liabilities
207972000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11441036
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11416716
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
114000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
114000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
152462000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
152392000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
157285000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
150124000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8194000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9173000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
301667000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
293457000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
558165000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
501429000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
282275000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
215545000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
251858000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
200205000
CY2023Q1 us-gaap Gross Profit
GrossProfit
30417000
CY2022Q1 us-gaap Gross Profit
GrossProfit
15340000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17924000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12386000
CY2023Q1 us-gaap Interest Expense
InterestExpense
1012000
CY2022Q1 us-gaap Interest Expense
InterestExpense
418000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
318000
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-52000
CY2023Q1 mlr Operating And Nonoperating Income Expense
OperatingAndNonoperatingIncomeExpense
18618000
CY2022Q1 mlr Operating And Nonoperating Income Expense
OperatingAndNonoperatingIncomeExpense
12856000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11799000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2484000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2579000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
419000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9220000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2065000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11425000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11417000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11431000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11421000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9220000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2065000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
979000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
25000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
979000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10199000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2090000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
284616000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2065000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
25000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2090000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
-5988
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
200000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
75000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2055000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
284926000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
293457000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9220000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
979000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10199000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
-2302
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
61000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
223000
CY2023Q1 mlr Apic Share Based Payment Arrangement Restricted Stock Unit Increase For Cost Recognition Shares
ApicShareBasedPaymentArrangementRestrictedStockUnitIncreaseForCostRecognitionShares
-214000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2059000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
301667000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9220000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2065000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3148000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2793000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
45000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
45000
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
61000
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
200000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
223000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
75000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-66000
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-37000
CY2023Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
55235000
CY2022Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
39960000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10320000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9434000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2193000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2992000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-88000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
38000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
44003000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21363000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1895000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1925000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2367000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1091000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6764000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28936000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1749000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4091000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1749000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4083000
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
10000000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2059000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2055000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2059000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7939000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10433000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25040000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40153000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54332000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29720000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29292000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1493000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
467000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
495000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
572000
CY2023Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 10pt 0pt;">1.          BASIS OF PRESENTATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 10pt 0pt;">The condensed consolidated financial statements of Miller Industries, Inc. and subsidiaries (the “Company”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. Nevertheless, the Company believes that the disclosures are adequate to make the financial information presented not misleading. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, to present fairly the Company’s financial position, results of operations and cash flows at the dates and for the periods presented. Interim results of operations are not necessarily indicative of results to be expected for the fiscal year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;">These condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The condensed consolidated financial statements include accounts of certain subsidiaries whose fiscal closing dates differ from December 31<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">st</sup> by 31 days (or less) to facilitate timely reporting.</p>
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9220000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2065000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11425000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11417000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
6000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
4000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11431000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11421000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
8
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
282275000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
215545000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
242000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2023Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0
CY2022Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0
CY2023Q1 mlr Inventory Chassis Net Of Reserves
InventoryChassisNetOfReserves
18125000
CY2022Q4 mlr Inventory Chassis Net Of Reserves
InventoryChassisNetOfReserves
18604000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
77852000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
75934000
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
42588000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
40655000
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
25866000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
18463000
CY2023Q1 us-gaap Inventory Net
InventoryNet
164431000
CY2022Q4 us-gaap Inventory Net
InventoryNet
153656000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29720000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40153000
CY2023Q1 us-gaap Lessee Finance Lease Existence Of Option To Extend
LesseeFinanceLeaseExistenceOfOptionToExtend
true
CY2023Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q1 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2023Q1 us-gaap Lessee Finance Lease Existence Of Option To Terminate
LesseeFinanceLeaseExistenceOfOptionToTerminate
true
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
254000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
292000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
254000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
83000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
884000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
876000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
9000
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
5000
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2022Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2023Q1 mlr Finance Lease Cost
FinanceLeaseCost
10000
CY2022Q1 mlr Finance Lease Cost
FinanceLeaseCost
6000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
88000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
106000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
86000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
166000
CY2023Q1 us-gaap Lease Cost
LeaseCost
184000
CY2022Q1 us-gaap Lease Cost
LeaseCost
278000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
88000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
107000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
31000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.032
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
0
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1135000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
96674000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
142028000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
138008000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
95293000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
121746000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
137998000
CY2023Q2 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2023-05-01
CY2023Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.18
CY2023Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-06-12
CY2023Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-06-05

Files In Submission

Name View Source Status
mlr-20230331_cal.xml Edgar Link unprocessable
mlr-20230331_pre.xml Edgar Link unprocessable
0001558370-23-007874-index-headers.html Edgar Link pending
0001558370-23-007874-index.html Edgar Link pending
0001558370-23-007874.txt Edgar Link pending
0001558370-23-007874-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlr-20230331.xsd Edgar Link pending
mlr-20230331x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mlr-20230331x10q002.jpg Edgar Link pending
mlr-20230331xex31d1.htm Edgar Link pending
mlr-20230331xex31d2.htm Edgar Link pending
mlr-20230331xex32d1.htm Edgar Link pending
mlr-20230331xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mlr-20230331_def.xml Edgar Link unprocessable
mlr-20230331_lab.xml Edgar Link unprocessable
mlr-20230331x10q_htm.xml Edgar Link completed